Vermeire S - Search Results

1

Therapeutic drug monitoring of biologics in inflammatory bowel disease: unmet needs and future perspectives.

Papamichael K, Afif W, Drobne D, Dubinsky MC, Ferrante M, Irving PM, Kamperidis N, Kobayashi T, Kotze PG, Lambert J, Noor NM, Roblin X, Roda G, Vande Casteele N, Yarur AJ, Arebi N, Danese S, Paul S, Sandborn WJ, Vermeire S, Cheifetz AS, Peyrin-Biroulet L; International Consortium for Therapeutic Drug Monitoring. Papamichael K, et al. Among authors: vermeire s. Lancet Gastroenterol Hepatol. 2022 Feb;7(2):171-185. doi: 10.1016/S2468-1253(21)00223-5. Lancet Gastroenterol Hepatol. 2022. PMID: 35026171 Free PMC article. Review.

2

Familial and sporadic inflammatory bowel disease: different entities?

Peeters M, Cortot A, Vermeire S, Colombel JF. Peeters M, et al. Among authors: vermeire s. Inflamm Bowel Dis. 2000 Nov;6(4):314-20. doi: 10.1002/ibd.3780060409. Inflamm Bowel Dis. 2000. PMID: 11149564 Review.

3

Serological diagnosis of inflammatory bowel disease.

Rutgeerts P, Vermeire S. Rutgeerts P, et al. Among authors: vermeire s. Lancet. 2000 Dec 23-30;356(9248):2117-8. doi: 10.1016/s0140-6736(00)03488-7. Lancet. 2000. PMID: 11191535 No abstract available.

4

Comparative study of ASCA (Anti-Saccharomyces cerevisiae antibody) assays in inflammatory bowel disease.

Vermeire S, Joossens S, Peeters M, Monsuur F, Marien G, Bossuyt X, Groenen P, Vlietinck R, Rutgeerts P. Vermeire S, et al. Gastroenterology. 2001 Mar;120(4):827-33. doi: 10.1053/gast.2001.22546. Gastroenterology. 2001. PMID: 11231936

5

Evidence for inflammatory bowel disease of a susceptibility locus on the X chromosome.

Vermeire S, Satsangi J, Peeters M, Parkes M, Jewell DP, Vlietinck R, Rutgeerts P. Vermeire S, et al. Gastroenterology. 2001 Mar;120(4):834-40. doi: 10.1053/gast.2001.22453. Gastroenterology. 2001. PMID: 11231937

6

Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease.

Peeters M, Joossens S, Vermeire S, Vlietinck R, Bossuyt X, Rutgeerts P. Peeters M, et al. Among authors: vermeire s. Am J Gastroenterol. 2001 Mar;96(3):730-4. doi: 10.1111/j.1572-0241.2001.03613.x. Am J Gastroenterol. 2001. PMID: 11280542

7

Optimizing anti-TNF treatment in inflammatory bowel disease.

Rutgeerts P, Van Assche G, Vermeire S. Rutgeerts P, et al. Among authors: vermeire s. Gastroenterology. 2004 May;126(6):1593-610. doi: 10.1053/j.gastro.2004.02.070. Gastroenterology. 2004. PMID: 15168370 Review.

8

Medical treatment of inflammatory bowel diseases.

Van Assche G, Vermeire S, Rutgeerts P. Van Assche G, et al. Among authors: vermeire s. Curr Opin Gastroenterol. 2005 Jul;21(4):443-7. Curr Opin Gastroenterol. 2005. PMID: 15930985 Review.

9

Association of organic cation transporter risk haplotype with perianal penetrating Crohn's disease but not with susceptibility to IBD.

Vermeire S, Pierik M, Hlavaty T, Claessens G, van Schuerbeeck N, Joossens S, Ferrante M, Henckaerts L, Bueno de Mesquita M, Vlietinck R, Rutgeerts P. Vermeire S, et al. Gastroenterology. 2005 Dec;129(6):1845-53. doi: 10.1053/j.gastro.2005.10.006. Gastroenterology. 2005. PMID: 16344053

10

Evaluation of short-term responsiveness and cutoff values of inflammatory bowel disease questionnaire in Crohn's disease.

Hlavaty T, Persoons P, Vermeire S, Ferrante M, Pierik M, Van Assche G, Rutgeerts P. Hlavaty T, et al. Among authors: vermeire s. Inflamm Bowel Dis. 2006 Mar;12(3):199-204. doi: 10.1097/01.MIB.0000217768.75519.32. Inflamm Bowel Dis. 2006. PMID: 16534421

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

860 results

Search Page